510(k) K770453
K770453 is an FDA 510(k) premarket notification submitted by Icn Pharmaceuticals, Inc. for the device "PHOSPHATASE PROCEDURE, TEKPOINT ALKALINE". The FDA issued a decision of Substantially Equivalent on May 3, 1977. The device falls under product code CIO (Thymolphthalein Monophosphate, Alkaline Phosphatase Or Isoenzymes), a Class II device regulated under 21 CFR 862.1050. Icn Pharmaceuticals, Inc. has 29 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 3, 1977
- Date Received
- Mar 8, 1977
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Thymolphthalein Monophosphate, Alkaline Phosphatase Or Isoenzymes
- Device Class
- Class II
- Regulation Number
- 862.1050
- Review Panel
- CH
- Submission Type
- 510(k)
Need the full FDA record for Icn Pharmaceuticals, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.